SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3076% below fair value
$2.38−0.23 (-8.64%)
Close on Nov 20, 2026Market cap $23.68MP/E –Yield –
Scynexis gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2014 it was $3.58M, up 548.2% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $3.58M | +548.2% |
| FY2013 | Dec 31, 2013 | $552.00K | – |
See a number that looks wrong?